AllianceBernstein L.P. (ATRC) reports 5.5% beneficial ownership in AtriCure
Rhea-AI Filing Summary
AllianceBernstein L.P. filed an amended Schedule 13G reporting beneficial ownership of AtriCure Inc common stock. As of June 30, 2026, AllianceBernstein reported beneficial ownership of 2,768,365 shares, representing 5.5% of AtriCure’s outstanding common stock. The shares are held solely for investment purposes in client discretionary investment advisory accounts.
AllianceBernstein reported sole voting power over 2,631,027 shares and sole dispositive power over 2,737,665 shares, with an additional 30,700 shares subject to shared dispositive power and no shared voting power. AllianceBernstein is a Delaware partnership and a majority-owned subsidiary of Equitable Holdings, Inc., but states it operates under independent management and makes independent decisions from its parent.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
beneficially owned financial
Sole Voting Power financial
dispositive power financial
discretionary investment advisory accounts financial
Schedule 13G regulatory
FAQ
What voting power does AllianceBernstein L.P. have over its AtriCure (ATRC) holdings?
What dispositive power does AllianceBernstein L.P. report for its AtriCure (ATRC) position?
What is the relationship between AllianceBernstein L.P. and Equitable Holdings, Inc. in this AtriCure (ATRC) filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.